Experiences with cytoreduction surgery plus hyperthermic intraperitoneal chemotherapy in Taiwan

Our hospital was the first institution to offer cytoreduction surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) in Taiwan. Therefore, we report our experience and outcomes among patients who underwent HIPEC. Since 2002, 164 eligible patients underwent HIPEC, and we excluded cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Mao-Chih, Lu, Chang-Yun, Chang, Wei-Wen, Wu, Szu-Yuan, Hsiao, Ping-Kun, Liu, Tse-Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500057/
https://www.ncbi.nlm.nih.gov/pubmed/28658135
http://dx.doi.org/10.1097/MD.0000000000007306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500057/
https://www.ncbi.nlm.nih.gov/pubmed/28658135
http://dx.doi.org/10.1097/MD.0000000000007306

Ejemplares similares